At5g62060 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At5g62060 antibody; MTG10.8 antibody; Putative F-box protein At5g62060 antibody
Target Names
At5g62060
Uniprot No.

Q&A

Basic Research Questions

  • What is AT5G62060 and why is it important in plant research?

    AT5G62060 encodes an F-box and associated interaction domains-containing protein in Arabidopsis thaliana . F-box proteins are important components of the SCF ubiquitin-ligase complexes that mediate protein degradation through the ubiquitin-proteasome pathway, playing crucial roles in various plant developmental processes, stress responses, and signaling pathways. The protein has been identified in studies related to plant developmental regulation, particularly in research focused on transcription factor networks.

  • How should I design experiments to validate the specificity of an AT5G62060 antibody?

    Validation of antibody specificity requires multiple approaches:

    • Western blot analysis comparing wild-type plants with AT5G62060 knockout/knockdown mutants

    • Preabsorption test with purified recombinant AT5G62060 protein

    • Cross-reactivity tests with closely related F-box proteins

    • Immunoprecipitation followed by mass spectrometry to confirm target identity

    • Immunolocalization in tissues with known expression patterns based on transcriptomic data

  • What sample preparation methods are optimal for AT5G62060 detection in plant tissues?

    For optimal detection:

    • Extract proteins using buffer containing 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail

    • Include reducing agents (DTT or β-mercaptoethanol) to break disulfide bonds

    • Consider tissue-specific extraction protocols based on AT5G62060 expression patterns

    • For membrane-associated fractions, use specialized extraction buffers with detergents

    • Fresh tissue extraction generally yields better results than frozen samples for preserving protein integrity

Advanced Research Applications

  • How can ChIP-seq be optimized when using AT5G62060 antibodies for transcription factor studies?

    Optimizing ChIP-seq with AT5G62060 antibodies requires:

    • Crosslinking optimization: Test different formaldehyde concentrations (1-3%) and incubation times (10-20 minutes)

    • Sonication parameters: Adjust to generate DNA fragments between 200-500bp

    • Antibody validation: Confirm specific binding through Western blot and immunoprecipitation before ChIP

    • Use appropriate controls including IgG control and input DNA

    • Consider specialized plant ChIP protocols that account for cell wall and plant-specific factors

    • Based on methods used in WRKY75 transcription factor studies, design primers targeting promoter regions of potential target genes

  • What are the considerations for detecting post-translational modifications of the AT5G62060 protein using specific antibodies?

    Key considerations include:

    • Determine potential modification sites through bioinformatic prediction

    • Use phospho-specific or ubiquitin-specific antibodies depending on the modification of interest

    • Apply phosphatase inhibitors (NaF, Na₃VO₄) for phosphorylation studies

    • Consider MG132 treatment to inhibit proteasomal degradation when studying ubiquitination

    • Employ 2D gel electrophoresis to separate modified protein forms before Western blotting

    • Validate antibody specificity for modified vs. unmodified protein forms using synthetic peptides

  • How can I reconcile contradictory data when the AT5G62060 antibody produces different results across experimental techniques?

    When facing contradictory results:

    • Evaluate antibody specificity in each technique separately

    • Consider epitope accessibility differences between methods (native vs. denatured conditions)

    • Assess potential post-translational modifications affecting epitope recognition

    • Review extraction methods for each technique and optimize for protein stability

    • Compare results with transcript-level data from RT-PCR or RNA-seq

    • Consider using multiple antibodies targeting different epitopes of AT5G62060

    • Employ genetic approaches (mutants, overexpression lines) to validate antibody findings

Experimental Troubleshooting

  • What are the most common causes of non-specific binding when using AT5G62060 antibodies, and how can they be addressed?

    Common causes and solutions:

    • Cross-reactivity with related F-box proteins: Increase wash stringency in immunoassays

    • Insufficient blocking: Optimize blocking agent (BSA, non-fat milk, commercial blockers) and concentration (3-5%)

    • High antibody concentration: Perform titration experiments to determine optimal dilution

    • Plant-specific compounds interference: Add PVP or PVPP (0.5-2%) to extraction and blocking buffers

    • Secondary antibody issues: Include additional blocking steps and consider using secondary antibodies pre-adsorbed against plant proteins

    • Consider the approach used for therapeutic antibody specificity testing, where antibodies were tested against experimental animal immunoglobulins

  • How can I improve sensitivity for detecting low-abundance AT5G62060 protein in different plant tissues?

    Strategies to improve detection sensitivity:

    • Enrich target protein through immunoprecipitation before Western blotting

    • Use signal amplification methods (tyramide signal amplification for immunohistochemistry)

    • Consider sample enrichment using subcellular fractionation

    • Employ more sensitive detection systems (ECL Prime, femto-ECL substrates)

    • Optimize protein extraction from specific tissues using tissue-specific protocols

    • Use detection methods similar to those described for TIC40 antibody

  • What controls should be included when using AT5G62060 antibodies in co-immunoprecipitation studies?

    Essential controls include:

    • Input sample (pre-IP fraction)

    • Non-specific IgG control precipitation

    • Knockout/knockdown mutant control

    • Reciprocal co-IP when possible

    • Protein expression control (Western blot of starting material)

    • RNase/DNase treatment controls if RNA/DNA binding is suspected

    • Competition experiments with recombinant protein or peptide

Advanced Research Questions

  • How can structure-guided design improve antibody specificity for the AT5G62060 protein?

    Structure-guided approaches include:

    • In silico analysis of protein structure to identify unique epitopes

    • Rational design of immunogens targeting specific domains

    • Combining random mutagenesis with structure-guided design as demonstrated in antibody development studies

    • Use computational modeling to predict antibody-antigen interactions

    • Design competitive peptides that can be used to validate antibody specificity

    • Apply next-generation sequencing to optimize antibody selection from libraries

    ApproachApplication to AT5G62060Expected Outcome
    Epitope mappingIdentify unique regions within F-box domainHigher specificity
    Surface charge analysisTarget distinctive charge distribution regionsReduced cross-reactivity
    Structural motif targetingFocus on regions unique to AT5G62060Improved selectivity
    Random mutagenesisOptimize binding affinity while maintaining specificityEnhanced sensitivity
  • What approaches can distinguish between AT5G62060 and other closely related F-box proteins in complex plant samples?

    Distinguishing approaches:

    • Develop antibodies against unique C-terminal domains

    • Use competitive peptide blocking with specific sequences

    • Employ 2D gel electrophoresis to separate proteins by both pI and molecular weight

    • Validate with mass spectrometry to confirm protein identity

    • Use gene-editing techniques (CRISPR) to create tagged versions of the endogenous protein

    • Consider preparation methods similar to those used for therapeutic antibody detection in complex samples

  • How can AT5G62060 antibodies be used to investigate protein-protein interactions within transcriptional complexes?

    Investigation approaches:

    • Sequential ChIP (ChIP-reChIP) to identify co-binding partners

    • Proximity ligation assay (PLA) to detect in situ interactions

    • Co-immunoprecipitation followed by mass spectrometry

    • Split luciferase complementation assays for in vivo interaction validation

    • BioID or APEX proximity labeling to identify interaction networks

    • FRET/FLIM analysis with fluorescently tagged antibodies or proteins

  • What methodologies can effectively track AT5G62060 protein levels during plant development and stress responses?

    Effective methodologies:

    • Time-course Western blot analysis with quantitative normalization

    • Multiplexed protein assays using differentially labeled antibodies

    • Immunohistochemistry on tissue sections at different developmental stages

    • Flow cytometry of protoplasts for quantitative single-cell analysis

    • Live cell imaging with fluorescently labeled antibody fragments

    • Consider experimental designs used in studies of other plant transcription factors such as WRKY75

  • How can I integrate antibody-based detection of AT5G62060 with other omics approaches for comprehensive functional studies?

    Integration strategies:

    • Correlate protein levels (Western blot) with transcript data (RNA-seq)

    • Combine ChIP-seq data with transcriptome analysis to identify direct targets

    • Integrate proteomics data with antibody-based detection for validation

    • Use antibodies to isolate protein complexes for subsequent interactome analysis

    • Correlate post-translational modification status with metabolomics data

    • Apply similar approaches to those used in studying transcription factor networks in Arabidopsis

Technical Considerations

  • What are the best strategies for long-term storage and handling of AT5G62060 antibodies to maintain sensitivity?

    Storage and handling best practices:

    • Store concentrated antibody stocks at -80°C in small aliquots

    • Working dilutions can be stored at 4°C with 0.02% sodium azide for 1-2 weeks

    • Avoid repeated freeze-thaw cycles (limit to 5 maximum)

    • Add stabilizing proteins (BSA, glycerol) for long-term storage

    • Test antibody activity periodically against positive control samples

    • Monitor for signs of degradation through SDS-PAGE analysis

    • Consider lyophilization for extended shelf life

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.